AddUp announces 2025–2026 Medical Advisory Board
AddUp, headquartered in Cébazat, France, has announced its 2025-2026 Medical Advisory Board. The board is intended to guide the company’s strategy in developing safe and compliant Additive Manufacturing applications for the medical device industry.
The 2025-2026 Medical Advisory Board comprises five professionals, each bringing knowledge and experience from various fields, including medical device product development, regulatory compliance, surgical innovation, and commercialisation.
The board consists of: Andy Christensen, Ed Domanski, David Morrow, Sam Onukuri and Jan Triani. Christensen, Domanski and Morrow are newly appointed for the 2025–2026 term.
“I’m always interested to learn more about where the industry for 3D printed medical devices is headed. AddUp has a unique value proposition and I’m excited to lend my thoughts in helping it succeed,” Christensen stated.
Andy Christensen: Christensen began working with Additive Manufacturing in the mid 1990s. His company Medical Modeling was focused exclusively on AM in healthcare and, in particular, personalised surgery. Medical Modeling manufactured the first FDA-cleared orthopaedic and spine additively manufactured titanium implants. In 2014, the company was sold to 3D Systems.
Ed Domanski: Domanski has over thirty years of experience leading businesses across the medical device industry. His work has included the addition of Additive Manufacturing in MedTech. Through his career, it is reported that Domanski generated over $2 billion in commercial growth.
“I joined the AddUp Advisory Board because I believe additive manufacturing is transforming how we design and deliver medical devices,” he stated. “My passion has always been improving the treatment and recovery of patients, and AddUp’s technology provides a powerful platform to make that impact on a global scale.“
David Morrow: Morrow has over twenty-five years in the MedTech industry, as well as acquisition leadership experience. One acquisition executed by his team was that of Johnson & Johnson’s first portfolio of additively manufactured orthopaedic implants. He has also overseen MedTech growth initiatives in digital surgery, robotics and biologics.
Sam Onukuri: Onukuri joined AddUp’s Medical Advisory Board in 2023, bringing over 30 years of expertise in medical device R&D, commercialisation, and materials science. Formerly Head of Johnson & Johnson’s 3D Printing Innovation group, he led the global integration of Additive Manufacturing across J&J’s businesses, driving advancements in materials, bioprinting, point-of-care solutions, and precision medicine.
Jan Triani: Triani also joined AddUp’s Medical Advisory Board in 2023, bringing over 20 years of experience in quality assurance and regulatory affairs for medical devices. She has worked with both global manufacturers and startups, and currently leads her own consulting practice, often serving as interim QA/RA Director. Triani has built two complete quality management systems, supported five FDA inspections, and authored more than 20 FDA submissions, including HDEs, 510(k)s, pre-submissions and expanded access for rare conditions.
